{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:50:40Z","timestamp":1784865040085,"version":"3.55.0"},"reference-count":34,"publisher":"Impact Journals, LLC","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2019,11,11]]},"DOI":"10.18632\/aging.102420","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:15:15Z","timestamp":1573517715000},"page":"9719-9737","source":"Crossref","is-referenced-by-count":39,"title":["Tanshinone IIA mediates SMAD7-YAP interaction to inhibit liver cancer growth by inactivating the transforming growth factor beta signaling pathway"],"prefix":"10.18632","volume":"11","author":[{"given":"Lifang","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, P.R. China"},{"name":"Institute for Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[{"name":"Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Niu","sequence":"additional","affiliation":[{"name":"Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixian","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuquan","family":"Tao","sequence":"additional","affiliation":[{"name":"Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute for Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghe","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchun","family":"Yu","sequence":"additional","affiliation":[{"name":"Institute for Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, P.R. China"},{"name":"Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2019,11,11]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.cgh.2015.08.014","article-title":"Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.","volume":"1","author":"El-Serag","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1007\/s00535-013-0921-z","article-title":"Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes.","volume":"4","author":"Kajiwara","year":"2014","journal-title":"J Gastroenterol"},{"key":"3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1756-8722-5-69","article-title":"Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization.","volume":"5","author":"Tang","year":"2012","journal-title":"J Hematol Oncol"},{"key":"4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.abb.2016.03.031","article-title":"Tanshinone A inhibits human esophageal cancer cell growth through miR-122-mediated PKM2 down-regulation.","volume":"59","author":"Huang","year":"2016","journal-title":"Arch Biochem Biophys"},{"key":"5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000452340","article-title":"Tanshinone IIA Affects Autophagy and Apoptosis of Glioma Cells by Inhibiting Phosphatidylinositol 3-Kinase\/Akt\/Mammalian Target of Rapamycin Signaling Pathway.","volume":"9","author":"Meng","year":"2017","journal-title":"Pharmacology"},{"key":"6","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.apsb.2015.07.008","article-title":"The antitumor effect of tanshinone IIA on anti-proliferation and decreasing VEGF\/VEGFR2 expression on the human non-small cell lung cancer A549 cell line.","volume":"5","author":"Mo","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.canlet.2017.05.013","article-title":"Tanshinone IIA inhibits beta-catenin\/VEGF-mediated angiogenesis by targeting TGF-beta1 in normoxic and HIF-1alpha in hypoxic microenvironments in human colorectal cancer.","volume":"40","author":"Li","year":"2017","journal-title":"Cancer Lett"},{"key":"8","first-page":"12","article-title":"High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer.","volume":"5","author":"Iljin","year":"2016","journal-title":"J Mol Biochem"},{"key":"9","doi-asserted-by":"publisher","first-page":"djt369","DOI":"10.1093\/jnci\/djt369","article-title":"TGF-beta: duality of function between tumor prevention and carcinogenesis.","volume":"10","author":"Grippo","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1038\/onc.2016.512","article-title":"An FGFR inhibitor converts the tumor promoting effect of TGF-beta by the induction of fibroblast-associated genes of hepatoma cells.","volume":"3","author":"Wu","year":"2017","journal-title":"Oncogene"},{"key":"11","doi-asserted-by":"publisher","first-page":"e294","DOI":"10.1038\/oncsis.2016.85","article-title":"Hepatocyte-specific Smad7 deletion accelerates DEN-induced HCC via activation of STAT3 signaling in mice.","volume":"6","author":"Vogel","year":"2017","journal-title":"Oncogenesis"},{"key":"12","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1038\/onc.2016.447","article-title":"Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-beta signaling in and promote progression of hepatocellular carcinoma.","volume":"3","author":"Xie","year":"2017","journal-title":"Oncogene"},{"key":"13","doi-asserted-by":"publisher","first-page":"7435","DOI":"10.1074\/jbc.M117.783662","article-title":"RNF11 sequestration of the E3 ligase SMURF2 on membranes antagonizes SMAD7 down-regulation of transforming growth factor beta signaling.","volume":"29","author":"Sanchez","year":"2017","journal-title":"J Biol Chem"},{"key":"14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/abbs\/gmu106","article-title":"The Hippo signaling pathway in liver regeneration and tumorigenesis.","volume":"4","author":"Chen","year":"2015","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"15","doi-asserted-by":"publisher","first-page":"8357","DOI":"10.1038\/ncomms9357","article-title":"MAP4K family kinases act in parallel to MST1\/2 to activate LATS1\/2 in the Hippo pathway.","volume":"6","author":"Halder","year":"2015","journal-title":"Nat Commun"},{"key":"16","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.jhep.2015.07.008","article-title":"Emerging evidence on the role of the Hippo\/YAP pathway in liver physiology and cancer.","volume":"6","author":"Camargo","year":"2015","journal-title":"J Hepatol"},{"key":"17","doi-asserted-by":"publisher","first-page":"11123","DOI":"10.1038\/ncomms11123","article-title":"Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-beta signalling pathways.","volume":"7","author":"Zhu","year":"2016","journal-title":"Nat Commun"},{"key":"18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1084\/jem.20111653","article-title":"TGF-beta synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth.","volume":"20","author":"Osada","year":"2012","journal-title":"J Exp Med"},{"key":"19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.stem.2013.12.009","article-title":"Hippo tips the TGF-beta scale in favor of pluripotency.","volume":"1","author":"Mullen","year":"2014","journal-title":"Cell Stem Cell"},{"key":"20","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/hep.26420","article-title":"Mutual interaction between YAP and CREB promotes tumorigenesis in liver cancer.","volume":"5","author":"Sun","year":"2013","journal-title":"Hepatology"},{"key":"21","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.1074\/jbc.M113.524819","article-title":"Cluster of differentiation 166 (CD166) regulated by phosphatidylinositide 3-Kinase (PI3K)\/AKT signaling to exert its anti-apoptotic role via yes-associated protein (YAP) in liver cancer.","volume":"28","author":"Sun","year":"2014","journal-title":"J Biol Chem"},{"key":"22","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1016\/j.cellsig.2014.09.011","article-title":"Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells.","volume":"2","author":"Wang","year":"2014","journal-title":"Cell Signal"},{"key":"23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.cell.2013.12.043","article-title":"Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer.","volume":"15","author":"Gregory","year":"2014","journal-title":"Cell"},{"key":"24","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1128\/MCB.01636-06","article-title":"Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.","volume":"2","author":"Chen","year":"2007","journal-title":"Mol Cell Biol"},{"key":"25","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3389\/fimmu.2018.01407","article-title":"Transforming Growth Factor-beta1\/Smad7 in Intestinal Immunity, Inflammation, and Cancer.","volume":"9","author":"Monteleone","year":"2018","journal-title":"Front Immunol"},{"key":"26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1042\/CS20140606","article-title":"Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma.","volume":"12","author":"Fabian","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/path.4206","article-title":"Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.","volume":"23","author":"Yu","year":"2013","journal-title":"J Pathol"},{"key":"28","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.celrep.2017.10.017","article-title":"TFCP2 Is Required for YAP-Dependent Transcription to Stimulate Liver Malignancy.","volume":"2","author":"Wang","year":"2017","journal-title":"Cell Rep"},{"key":"29","doi-asserted-by":"publisher","first-page":"15280","DOI":"10.1038\/ncomms15280","article-title":"The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis.","volume":"8","author":"Sun","year":"2017","journal-title":"Nat Commun"},{"key":"30","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1073\/pnas.1610223114","article-title":"The nonreceptor tyrosine kinase c-Src attenuates SCF(beta-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.","volume":"11","author":"Shaul","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jsbmb.2009.01.011","article-title":"The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS.","volume":"11","author":"Zhang","year":"2009","journal-title":"J Steroid Biochem Mol Biol"},{"key":"32","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3892\/or.2016.4857","article-title":"Tanshinone IIA decreases the protein expression of EGFR, and IGFR blocking the PI3K\/Akt\/mTOR pathway in gastric carcinoma AGS cells both in vitro and","volume":"3","author":"Chiu","year":"2016","journal-title":"Oncol Rep"},{"key":"33","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1016\/j.bbrc.2018.07.169","article-title":"Bufalin inhibits cell proliferation and migration of hepatocellular carcinoma cells via APOBEC3F induced intestinal immune network for IgA production signaling pathway.","volume":"50","author":"Ma","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"34","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.7150\/jca.21018","article-title":"Huaier Restrains Proliferative and Migratory Potential of Hepatocellular Carcinoma Cells Partially Through Decreased Yes-Associated Protein 1.","volume":"8","author":"Yu","year":"2017","journal-title":"J Cancer"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T19:38:46Z","timestamp":1599075526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,11]]},"references-count":34,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2019,11,15]]}},"alternative-id":["102420","31711043"],"URL":"https:\/\/doi.org\/10.18632\/aging.102420","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,11]]}}}